123 related articles for article (PubMed ID: 8096419)
1. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
[TBL] [Abstract][Full Text] [Related]
2. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Ransford RA; Langman MJ
Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
[TBL] [Abstract][Full Text] [Related]
3. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease.
Laasila K; Leirisalo-Repo M
Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
Gran JT; Myklebust G
Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
[TBL] [Abstract][Full Text] [Related]
5. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
Mundo A; Pedone V; Lamanna G; Cervini C
Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
[TBL] [Abstract][Full Text] [Related]
6. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
7. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
[TBL] [Abstract][Full Text] [Related]
8. Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine.
Farr M; Scott DG; Bacon PA
Drugs; 1986; 32 Suppl 1():49-53. PubMed ID: 2877853
[TBL] [Abstract][Full Text] [Related]
9. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
Boyd O; Gibbs AR; Smith AP
Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
[TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
Laversuch CJ; Collins DA; Charles PJ; Bourke BE
Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172
[TBL] [Abstract][Full Text] [Related]
11. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
[TBL] [Abstract][Full Text] [Related]
12. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
Grindulis KA; McConkey B
Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
[TBL] [Abstract][Full Text] [Related]
13. Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages.
Wilkieson CA; Madhok R; Hunter JA; Capell HA
Q J Med; 1993 Aug; 86(8):501-5. PubMed ID: 8105504
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
Situnayake RD; Grindulis KA; McConkey B
Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
[TBL] [Abstract][Full Text] [Related]
15. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
[TBL] [Abstract][Full Text] [Related]
17. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
Kitas GD; Farr M; Waterhouse L; Bacon PA
Scand J Rheumatol; 1992; 21(5):220-5. PubMed ID: 1359635
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
Donovan S; Hawley S; MacCarthy J; Scott DL
Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
[TBL] [Abstract][Full Text] [Related]
19. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
Grindulis KA; McConkey B
Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
[TBL] [Abstract][Full Text] [Related]
20. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
